These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 35338336)
1. Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database. Kim HL; Hwang D; Lee JH; Lee HY; Ihm SH; Kim KI; Shin J; Park S; Kim DH; Sung KC Hypertens Res; 2022 May; 45(5):758-768. PubMed ID: 35338336 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Suchard MA; Schuemie MJ; Krumholz HM; You SC; Chen R; Pratt N; Reich CG; Duke J; Madigan D; Hripcsak G; Ryan PB Lancet; 2019 Nov; 394(10211):1816-1826. PubMed ID: 31668726 [TBL] [Abstract][Full Text] [Related]
3. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis. Jeffers BW; Robbins J; Bhambri R Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586 [TBL] [Abstract][Full Text] [Related]
5. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker. Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625 [TBL] [Abstract][Full Text] [Related]
6. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis. Zhang J; Tong A; Dai Y; Niu J; Yu F; Xu F J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1082-1090. PubMed ID: 31241860 [TBL] [Abstract][Full Text] [Related]
7. Renin-Angiotensin System Inhibitors vs Other Antihypertensives in Hypertensive Blacks: A Meta-Analysis. Palla M; Ando T; Androulakis E; Telila T; Briasoulis A J Clin Hypertens (Greenwich); 2017 Apr; 19(4):344-350. PubMed ID: 27378313 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up. Jeong HS; Lim HS; Park HJ; Lee WS; Choi JO; Lee HS; Jo SH; Hong SJ Sci Rep; 2021 Jan; 11(1):1783. PubMed ID: 33469103 [TBL] [Abstract][Full Text] [Related]
9. Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II? Hwong WY; Bots ML; Selvarajah S; Abdul Aziz Z; Sidek NN; Spiering W; Kappelle LJ; Vaartjes I PLoS One; 2016; 11(11):e0166524. PubMed ID: 27846309 [TBL] [Abstract][Full Text] [Related]
10. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154 [TBL] [Abstract][Full Text] [Related]
14. Comparing Outcomes Between Thiazide Diuretics and Other First-line Antihypertensive Drugs in Long-term Nursing Home Residents. Boockvar KS; Song W; Lee S; Intrator O Clin Ther; 2020 Apr; 42(4):583-591. PubMed ID: 32229030 [TBL] [Abstract][Full Text] [Related]
15. The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials. Chen GJ; Yang MS PLoS One; 2013; 8(3):e57854. PubMed ID: 23483932 [TBL] [Abstract][Full Text] [Related]
16. Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands. Li X; Bijlsma MJ; Bos JHJ; Schuiling-Veninga CCM; Hak E BMJ Open; 2023 Aug; 13(8):e068721. PubMed ID: 37558444 [TBL] [Abstract][Full Text] [Related]
17. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis. Ren L; Yu S; Xu W; Overton JL; Chiamvimonvat N; Thai PN J Cardiol; 2021 May; 77(5):482-491. PubMed ID: 33168337 [TBL] [Abstract][Full Text] [Related]
18. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis. Pongpanich P; Pitakpaiboonkul P; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P Int Urol Nephrol; 2018 Dec; 50(12):2261-2278. PubMed ID: 30324578 [TBL] [Abstract][Full Text] [Related]
19. Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study. Yang R; Tang J; Kuang M; Liu H Ann Med; 2023 Dec; 55(1):276-284. PubMed ID: 36594446 [TBL] [Abstract][Full Text] [Related]
20. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]